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The introduction of antimicrobial agents to
treat human disease was one of the most sig-
niﬁcant public health accomplishments of the
20th century. Although many factors (e.g.,
improvements in sanitation, nutrition, and
standard of living) worked in concert with
antibiotic therapy to control and limit infec-
tious disease transmission, antibiotic therapy
was unique in that it not only allowed for the
prevention but also for the curing and control
of certain diseases (Barker 1999; Cohen
1992). Although the introduction and success-
ful development of this therapeutic class of
agents represents a signiﬁcant medical achieve-
ment, this success has also led to complacency
within both greater society and the scientiﬁc
community with regard to the development of
bacterial resistance (Neu 1992). That micro-
organisms possess the ability to develop resis-
tance to antibiotics was recognized soon after
the introduction of antimicrobial therapy,
when resistant bacteria were initially identiﬁed
in the 1930s (Smith and Coast 2002; Virk and
Steckelberg 2000). Reoccurring episodes of
infection with multiple resistant organisms
have affected hospitals since the early 1950s
when penicillin-resistant staphylococci initially
emerged (Cohen 1992). In spite of the
increased understanding of the factors con-
tributing to the development of resistance over
the last 60 years, the extent of this problem has
not decreased with time and is currently among
the strongest global threats to the treatment of
infectious disease (Conly 2002). The degree to
which this problem has progressed is demon-
strated by the fact that resistance has developed
against all available classes of antibiotics (Rao
1998; Virk and Steckelberg 2000).
As a result of the significant difficulties
associated with the accurate measurement of
airborne bacteria, little data exist on the con-
centration of bacteria in indoor air in compari-
son to other airborne contaminants [Institute
of Medicine Committee on Damp Indoor
Spaces and Health (IOM) 2004]. Although
there are signiﬁcant difﬁculties in measuring
airborne concentrations of most bioaerosols,
the health effects associated with exposure to
aerosolized bacteria have received less research
attention than those associated with exposure
to other organic dusts, such as molds and ani-
mal allergens. Also, many bacteria have tradi-
tionally been thought of as infectious
organisms, with disease resulting only from
transmission via large droplets over short dis-
tances or through contact with contaminated
surfaces (Roy and Milton 2004). Roy and
Milton (2004) suggested that this paradigm be
questioned and that there is a need for
improved understanding of aerosol-acquired
disease. This need is made more urgent by the
increasing environmental burden of antibiotic-
resistant bacteria.
Multidrug-resistant Staphylococcus aureus is
an example of a bacterium for which the role
of exposure to aerosolized organisms in disease
transmission should be more closely evaluated.
An international survey of infections due to
Staphylococcus species resulted in the finding
that S. aureus was the most prevalent cause of
hospital- and community-acquired blood-
stream, skin and soft tissue, and lower respira-
tory infection (Diekema et al. 2001). In the
hospital setting, the most common mode of
transmission of resistant S. aureus is close con-
tact with infected persons or with health-care
workers with contaminated hands or clothing
(Cooper et al. 2004). Recent evidence sug-
gests, however, that airborne dispersal and
transmission may also be important (Beggs
2003; Cooper et al. 2004; Roberts et al.
2006), and case studies implicating airborne
transmission in the hospital setting have been
published in the literature (Cotterill et al.
1996; Wagenvoort et al. 1993). Although
drug-resistant S. aureus has historically been a
significant problem only in hospitals, the
urgent need for further study of the ambient
airborne concentrations and the role of air-
borne transmission of this organism in non-
hospital environments is demonstrated by the
increasing prevalence of methicillin-resistant
S. aureus (MRSA) infections in the community
(Chambers 2001). Most alarming about this
trend is that infection has been observed
among individuals with and without known
risk factors (Gorak et al. 1999).
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OBJECTIVE: In this study we evaluated the levels of Staphylococcus aureus and antibiotic-resistant
S. aureus in colony-forming units (CFU) per cubic meter of air.
DESIGN: We used Andersen two-stage samplers to collect bioaerosol samples from 24 houses in
El Paso, Texas, using tryptic soy agar as the collection media, followed by the replicate plate
method on Chapman Stone selective medium to isolate S. aureus. The Kirby-Bauer disk diffusion
method was used to determine antibiotic resistance to ampicillin, penicillin, and cefaclor, which
represent two distinct classes of antibiotics. 
RESULTS: The average recovered concentration of respirable heterotrophic organisms found outside
each home was 345.38 CFU/m3, with an average of 12.63 CFU/m3 for S. aureus. The average
recovered concentration of respirable heterotrophic organisms found inside each home was 460.23
CFU/m3, with an average of 15.39 CFU/m3 for S. aureus. The respirable S. aureus recovered from
inside each home had an average resistance of 54.59% to ampicillin and 60.46%. to penicillin.
Presence of cefaclor-resistant and of multidrug-resistant S. aureus was the same, averaging 13.20%
per house. The respirable S. aureus recovered from outside each home had an average resistance of
34.42% to ampicillin and 41.81% to penicillin. Presence of cefaclor-resistant and of multidrug-
resistant S. aureus was the same, averaging 13.96% per house. 
CONCLUSIONS: This study indicates that antibiotic-resistant bioaerosols are commonly found
within residential homes. Our results also suggest that resistant strains of airborne culturable
S. aureus are present in higher concentrations inside the study homes than outside the homes.
KEY WORDS: antibiotic resistant, bioaerosols, residential indoor air, Staphylococcus aureus. Environ
Health Perspect 114:1859–1864 (2006). doi:10.1289/ehp.9585 available via http://dx.doi.org/
[Online 7 September 2006]The primary objective of this study was to
determine the levels of respirable S. aureus,
including antibiotic-resistant and multidrug-
resistant S. aureus (those resistant to at least two
classes of antibiotics) found within the bio-
aerosols of residential homes. We hypothesized
that S. aureus, including antibiotic-resistant
and multidrug-resistant S. aureus, were present
in the bioaerosols of the average home. 
Methods
Sample collection. Indoor and outdoor cultur-
able bacterial bioaerosol samples were collected
in El Paso, Texas, from 24 one-story houses
that had no basement or attic. These 24 houses
were randomly selected from a separate larger
study of 50 houses that had been identified
when a solicitation for study participation was
sent to faculty, staff, and students at the
University of Texas School of Public Health,
El Paso Regional Campus, and the University
of Texas at El Paso (Mota LC, Gibbs SG,
Green CF, Payan F, Tarwater PM, Ortiz M,
unpublished data). These houses contained
no visible microbial issues; no adverse health
issues that could be related to microbial 
contamination of the home had been previ-
ously reported by the occupants. Protocols were
in accordance with Human Subject and Health
Insurance Portability and Accountability Act
approval through the University of Texas
School of Public Health. Samples were taken
during spring (March, April, and May) of
2006, with sampling conducted at different
times of day to accommodate the needs of the
home owners.
We used methods adapted from previous
work (Gibbs et al. 2004, 2006; Green et al.
2003; Mota LC, Gibbs SG, Green CF, Payan
F, Tarwater PM, Ortiz M, unpublished data).
Duplicate bioaerosol samples were collected
inside each house using Andersen two-stage
viable microbial particle sizing sampler instru-
ments (Tisch Environmental, Cleves, OH)
(Andersen Samplers Inc. 1976.) The Andersen
two-stage sampler is a cascade impactor with
200 oriﬁces for each of the two stages; the sam-
pler separates particles according to their size
onto one of two stages. The nonrespirable stage
collects particles > 8 µm onto a media-filled
petri dish, and the respirable stage collects parti-
cles of 0.8–8 µm onto a second media-filled
petri dish. Separate equipment, including a
pump (Gast Oil-less Pressure/Vacuum Pump,
Gast Manufacturing, Inc., Benton Harbor, MI)
and Andersen two-stage sampler were used to
duplicate each site. All pumps were calibrated
to 28.3 L/min using the TriCal Laboratory/
Field Audit Calibrator (BGI Incorporated,
Waltham, MA) before each sampling event
(Dacarro et al. 2003). The samplers were placed
on a tripod 1 m above the ﬂoor surface in the
center of the main living area to simulate the
human breathing zone (Hyvarinen et al. 2001;
Pastuska et al. 2000; Sterling and Lewis 1998). 
The Andersen two-stage samplers were
loaded with plates of tryptic soy agar (TSA;
Difco Laboratories, Detroit, MI), an excellent
general agar used to culture a variety of bacter-
ial microorganisms. Duplicate 10- and 15-min
air samples were taken at each home. Various
climatic conditions were measured, including
temperature, relative humidity, and baromet-
ric pressure, using a portable weather station
(Traceable Digital Barometer Module;
Calibration Control Company, Friendswood,
TX). All equipment and materials were han-
dled using aseptic technique to ensure that the
bioaerosol samples were not contaminated. All
samples were returned to the laboratory for
analysis within 2 hr of sample collection. 
At the laboratory, the plates were placed in
an inverted position in an incubator at 35°C.
The colonies were counted after 24 and 48 hr
to determine if the plates were overgrown.
After 48 hr of incubation, the plates were
inverted and refrigerated at 4°C until use for
the replica plate method (Lederberg and
Lederberg 1952). We counted colonies for
each plate and calculated the total number of
Gandara et al.
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Table 2. Summary of climatic conditions for all homes.
Mean ± SD Minimum Maximum
Temperature (°C)
Inside 18.96 ± 2.14 15 24
Outside 15.38 ± 6.01 7 30
Relative humidity (%)
Inside 27.08 ± 3.96 23 42
Outside 27.50 ± 4.27 20 38
Barometric pressure (mmHg)
Inside 882.63 ± 7.20 869 895
Outside 882.58 ± 7.08 869 894
Table 1. NCCLS zone diameters used to categorize S. aureus recovered as susceptible, intermediate, or
resistant.
Zone diameter interpretive standards (mm)a
Antimicrobial agent Disk potency (µg) Resistant Intermediate Susceptible
Ampicillin 10 ≤ 28 — ≥ 29
Cefaclor 30 ≤ 14 15–17 ≥ 18
Penicillin 10 ≤ 28 — ≥ 29
aThese standards were adapted from NCCLS (1997, 2000, 2001).
Table 3. Average recovered concentrations (CFU/m3) of respirable S. aureus and heterotrophic organisms
from inside each home. 
House S. aureus Heterotrophic organisms S. aureus within heterotrophic organisms (%)
1 2.94 173.73 1.69
2 7.36 692.87 1.06
3 4.42 607.18 0.73
4 29.74 389.87 7.63
5 17.08 623.38 2.74
6 9.42 839.22 1.12
7 11.19 505.89 2.21
8 5.01 154.59 3.24
9 9.42 456.12 2.07
10 37.69 883.39 4.27
11 13.55 274.15 4.94
12 20.02 790.64 2.53
13 20.02 673.14 2.97
14 3.53 328.92 1.07
15 13.25 254.71 5.20
16 0.59 209.95 0.28
17 6.48 441.11 1.47
18 1.77 655.48 0.27
19 3.24 214.66 1.51
20 2.65 373.67 0.71
21 39.46 318.61 12.38
22 53.30 664.31 8.02
23 21.20 336.28 6.30
24 35.92 178.74 20.10
Mean 15.39 460.23 3.94
Q0 0.59 154.59 0.27
Q1 4.20 269.29 1.11
Q2 10.31 415.49 2.37
Q3 20.32 657.69 5.01
Q4 53.30 883.39 20.10culturable colony forming units (CFUs) per
cubic meter (Green et al. 2003; Meklin et al.
2002). Only the TSA plates from the res-
pirable portion were evaluated using the replica
plate method and Kirby-Bauer procedures;
therefore, the data presented in the present
study deal only with the culturable respirable
portion of bioaerosols. 
Isolation and speciation. We used the
replica plate method to identify the recovered
aerosolized culturable bacteria by transferring
the bacterial colonies onto a selective medium
(Lederberg and Lederberg 1952). For this
method we used Chapman Stone medium
(CSM; Difco Laboratories) for identiﬁcation
of S. aureus. After pressing of the CSM, TSA
was used as a final control for the method,
being pressed ﬁrst and last to ensure that the
organisms were completely transferred to all
plates. All plates were incubated at 35°C and
counted at 24 and 48 hr. The presence of
S. aureus was further confirmed using Bacto
coagulase plasma (Fisher Scientiﬁc, Houston,
TX). Once counted, the plates were refriger-
ated in an inverted position at 4°C until used
for the Kirby-Bauer disk diffusion method.
Antimicrobial susceptibility testing. We
analyzed the antibiotic-resistant characteristics
of up to ﬁve S. aureus isolates collected from the
respirable plate of each sample using the Kirby-
Bauer disk diffusion method (Bauer et al.
1966). Only organisms that could be isolated
from the CSM and cultured using a slant tube
were evaluated for antibiotic resistance. The
method was conducted in duplicate for each
organism evaluated. If the duplicate analysis did
not result in the same resistance profile, the
organism was not included in the analysis. A
sterile loop was used to transfer the micro-
organism being tested to a tube of phosphate-
buffer water until the tube was the same
turbidity as the 0.5 McFarland standard, which
resulted in an estimated 108 CFUs/mL. Room
temperature Mueller-Hinton agar (MHA;
Difco Laboratories) plates were used to evaluate
each of the microorganisms for antibiotic resis-
tance. Once the organism was placed onto the
MHA, it was allowed to dry before the disks
containing the antibiotics were placed onto the
MHA surface using a Sensi-Disk 6-Place Self-
Tamping Dispenser (Baltimore Biological
Laboratory, Cockeysville, Maryland). The disks
were allowed to settle before being inverted and
placed in an incubator at 35°C. The plates were
checked for susceptibility after 48 hr. The zones
of inhibition were recorded for all of the plates,
and a determination was made as to whether
the microorganism was susceptible, intermedi-
ately resistant, or resistant to each antibiotic
evaluated using National Committee for
Clinical Laboratory Standards (NCCLS 1997,
2000, 2001). Table 1 provides the specific
NCCLS zone diameters used to categorize
S. aureus. An organism was not included in
the tabulation of results if the antibiotic disk
had dislodged from the media or if the dupli-
cates did not result in the same antibiotic-
resistance proﬁle.
We used three types of Antibiotic Suscep-
tibility Test Disks (Difco Laboratories) for the
Kirby-Bauer method. These three antibiotics
(10 µg ampicillin, 10 µg penicillin, and 30 µg
cefaclor), chosen because they are commonly
used in human medicine, represent two dis-
tinct classes of antibiotics. Ampicillin and
penicillin are both penicillins, and cefaclor is a
second generation cephalosporin. Multidrug
resistance is defined as resistance to at least
two different classes of antibiotics; therefore,
any organism in this study that was resistant to
cefaclor and either ampicillin or penicillin was
deemed multidrug resistant. 
Quality assurance and quality control was
maintained throughout the study using aseptic
techniques. All sampling material that could be
autoclaved was autoclaved for 15 min at 15 psi
and 121°C. The Andersen two-stage samplers
were sterilized after each use, washed, and then
sterilized again before their next use. All other
items were disinfected with a 70% ethanol
solution after each sampling trip and before the
next sampling trip. For negative controls, we
used empty plates of TSA that were taken to
the sampling site during collection. S. aureus
(ATCC 25923; American Type Culture
Collection, Manassas, VA) was used as positive
control. We applied S. aureus (ATCC 25923)
to the CSM to ensure that it would be able to
culture the selected organism. We also tested
the control organisms in the Kirby-Bauer
method to ensure that antibiotics used would
inhibit growth of a nonresistant culture.
Results
Climatic conditions measured both inside and
outside each home during the course of the
study showed an expected variation for a study
conducted during the spring season (Table 2). 
The average recovered concentration of res-
pirable heterotrophic organisms found within
each home was 460.23 CFU/m3 (Table 3). A
quartile (Q) representation shows the distribu-
tion of respirable heterotrophic organisms from
inside the homes as follows: Q0 = 154.59, Q1 =
269.29, Q2 = 415.49, Q3 = 657.69, and Q4 =
883.39 CFU/m3. The average recovered con-
centration of S. aureus found within each home
was 15.39 CFU/m3 (Table 3). A quartile repre-
sentation shows the distribution of respirable
S. aureus from inside the homes at Q0 = 0.59,
Q1 = 4.20, Q2 = 10.31, Q3 = 20.32, and Q4 =
53.30 CFU/m3. This results in an average res-
pirable percentage of recovered culturable
S. aureus to heterotrophic organisms of 3.94%
(Q0 = 0.27%, Q1 = 1.11%, Q2 = 2.37%, Q3 =
5.01%, and Q4 = 20.10%). 
The average recovered concentration of
respirable heterotrophic organisms found
outside each home was 345.38 CFU/m3
(Table 4). The distribution of respirable
Antibiotic-resistant residential indoor bioaerosols
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Table 4. Average recovered concentrations (CFU/m3) of respirable S. aureus and heterotrophic organisms
from outside each home. 
House S. aureus Heterotrophic organisms S. aureus within heterotrophic organisms (%)
1 4.12 223.20 1.85
2 7.66 159.01 4.81
3 3.83 723.20 0.53
4 0.00 62.43 0.00
5 5.89 213.19 2.76
6 4.12 243.42 1.69
7 24.73 278.56 8.88
8 2.36 137.22 1.72
9 8.83 356.30 2.48
10 5.89 81.27 7.25
11 2.94 242.05 1.22
12 10.60 441.11 2.40
13 9.42 294.46 3.20
14 0.59 108.36 0.54
15 32.98 883.39 3.73
16 2.36 443.46 0.53
17 13.55 402.83 3.36
18 2.36 883.39 0.27
19 6.48 375.74 1.72
20 7.07 574.20 1.23
21 74.79 641.64 11.66
22 45.35 378.09 11.99
23 16.49 44.17 37.33
24 10.60 98.35 10.78
Mean 12.63 345.38 5.08
Q0 0.00 44.17 0.00
Q1 3.61 153.56 1.23
Q2 6.77 286.51 2.44
Q3 11.34 441.70 5.42
Q4 74.79 883.39 37.33heterotrophic organisms from outside the
homes by quartile were Q0 = 44.17, Q1 =
153.56, Q2 = 286.51, Q3 = 441.70, and
Q4 = 883.39 CFU/m3. The average recovered
concentration of S. aureus found outside each
home was 12.63 CFU/m3 (Table 4). A quar-
tile representation shows the distribution of
respirable S. aureus from outside the homes at
Q0 = 0.00, Q1 = 3.61, Q2 = 6.77, Q3 = 11.34,
and Q4 = 74.79 CFU/m3. This results in an
average respirable percentage of recovered cul-
turable S. aureus to heterotrophic organisms
of 5.08% (Q0 = 0.00%, Q1 = 1.23%, Q2 =
2.44%, Q3 = 5.42%, and Q4 = 37.33%);
indicating that, on average, S. aureus repre-
sents 5.08% of the recovered culturable out-
door bioaerosol. 
The respirable S. aureus recovered from
inside each home had an average resistance to
ampicillin of 54.59% (Q0 = 0.00%, Q1 =
34.31%, Q2 = 61.54%, Q3 = 67.95%, and Q4
= 100.00%) (Table 5). The average resistance
to penicillin was 60.46% for each home (Q0 =
0.00%, Q1 = 45.00%, Q2 = 62.50%, Q3 =
75.00%, and Q4 = 100.00%). Presence of
cefaclor-resistant and of multidrug-resistant
S. aureus was the same, averaging 13.20% per
house (Q0 = 0.00%, Q1 = 12.50%, Q2 =
23.61%, Q3 = 60.00%, and Q4 = 60.00%). 
The average resistance to ampicillin of res-
pirable S. aureus recovered from outside each
home was 34.42% (Q0 = 0.00%, Q1 = 0.00%,
Q2 = 33.33%, Q3 = 50.00%, and Q4 =
100.00%) (Table 6). The average resistance to
penicillin was 41.81% for each home (Q0 =
0.00%, Q1 = 0.00%, Q2 = 40.20%, Q3 =
72.50%, and Q4 = 100.00%). Presence of
cefaclor-resistant and of multidrug-resistant
S. aureus was the same, averaging 13.96% per
house (Q0 = 0.00%, Q1 = 0.00%, Q2 =
0.00%, Q3 = 20.83%, and Q4 = 100.00%). 
Using a paired t-test, we found that resis-
tant strains of airborne culturable S. aureus
were significantly higher inside the study
homes than outside the homes. However, we
found no significant difference between the
concentrations of S. aureus inside versus out-
side the homes.
Discussion
The present study was conducted over a
3-month period during spring 2006 to test the
hypothesis that S. aureus, including antibiotic-
resistant and multidrug-resistant S. aureus, are
present in the bioaerosol of the average home.
Study ﬁndings not only support our hypothesis
but also suggest that resistant strains of air-
borne culturable S. aureus are present in higher
concentrations inside the study homes than
outside of the homes (Tables 5 and 6). This
data trend suggests the presence of an indoor
source of these organisms. Although this trend
may be, in part, the result of the signiﬁcantly
higher concentrations of total heterotrophic
Gandara et al.
1862 VOLUME 114 | NUMBER 12 | December 2006 • Environmental Health Perspectives
Table 6. Antibiotic resistance of evaluated recoverable respirable S. aureus from outside each home. 
Ampicillin Penicillin  Cefaclor  Multidrug 
House NN r Percent Nr Percent Nr Percent Nr Percent
1 3 1 33.33 3 100.00 1 33.33 1 33.33
2 2 0 0.00 0 0.00 0 0.00 0 0.00
3 3 1 33.33 1 33.33 1 33.33 1 33.33
4a 0 ————————
5 2 0 0.00 0 0.00 0 0.00 0 0.00
6 2 0 0.00 0 0.00 0 0.00 0 0.00
7 10 7 70.00 7 70.00 0 0.00 0 0.00
8 1 0 0.00 0 0.00 0 0.00 0 0.00
9 5 1 20.00 1 20.00 0 0.00 0 0.00
10 1 0 0.00 0 0.00 0 0.00 0 0.00
11a 0 ————————
12 6 2 33.33 3 50.00 0 0.00 0 0.00
13 7 5 71.43 6 85.71 0 0.00 0 0.00
14a 0 ————————
15 4 1 25.00 1 25.00 0 0.00 0 0.00
16 2 0 0.00 0 0.00 0 0.00 0 0.00
17 5 4 80.00 4 80.00 2 40.00 2 40.00
18 1 1 100.00 1 100.00 1 100.00 1 100.00
19 2 1 50.00 1 50.00 0 0.00 0 0.00
20 2 1 50.00 2 100.00 1 50.00 1 50.00
21 17 8 47.06 8 47.06 1 5.88 1 5.88
22 4 1 25.00 1 25.00 0 0.00 0 0.00
23a 0 ————————
24 6 3 50.00 3 50.00 1 16.67 1 16.67
Mean 34.42 41.81 13.96 13.96
Q0 0.00 0.00 0.00 0.00
Q1 0.00 0.00 0.00 0.00
Q2 33.33 40.20 0.00 0.00
Q3 50.00 72.50 20.83 20.83
Q4 100.00 100.00 100.00 100.00
Abbreviations: N, number or organisms evaluated; Nr, number of resistant organisms.
aNo organisms could be isolated for resistance testing.
Table 5. Antibiotic resistance of evaluated recoverable respirable S. aureus from inside each home. 
Ampicillin Penicillin  Cefaclor  Multidrug 
House NN r Percent Nr Percent Nr Percent Nr Percent
1 1 0 0.00 0 0.00 0 0.00 0 0.00
2 6 2 33.33 3 50.00 1 16.67 1 16.67
3 7 2 28.57 2 28.57 0 0.00 0 0.00
4 8 6 75.00 6 75.00 2 25.00 2 25.00
5 7 4 57.14 5 71.43 2 28.57 2 28.57
6 8 5 62.50 4 50.00 0 0.00 0 0.00
7 8 2 25.00 3 37.50 1 12.50 1 12.50
8 3 2 66.67 3 100.00 0 0.00 0 0.00
9 4 1 25.00 3 75.00 1 25.00 1 25.00
10 17 6 35.29 6 35.29 1 5.88 1 5.88
11 8 6 75.00 5 62.50 1 12.50 1 12.50
12 9 6 66.67 6 66.67 2 22.22 2 22.22
13 11 7 63.64 7 63.64 0 0.00 0 0.00
14 5 2 40.00 2 40.00 1 20.00 1 20.00
15 16 8 50.00 8 50.00 4 25.00 4 25.00
16a 0————————
17 5 4 80.00 4 80.00 3 60.00 3 60.00
18 6 3 50.00 3 50.00 0 0.00 0 0.00
19 2 2 100.00 2 100.00 0 0.00 0 0.00
20 3 2 66.67 3 100.00 0 0.00 0 0.00
21 13 9 69.23 9 69.23 1 7.69 1 7.69
22 12 4 33.33 4 33.33 0 0.00 0 0.00
23 13 8 61.54 8 61.54 2 15.38 2 15.38
24 11 10 90.91 10 90.91 3 27.27 3 27.27
Mean 54.59 60.46 13.20 13.20
Q0 0.00 0.00 0.00 0.00
Q1 34.31 45.00 12.50 12.50
Q2 61.54 62.50 23.61 23.61
Q3 67.95 75.00 60.00 60.00
Q4 100.00 100.00 60.00 60.00
Abbreviations: N, number or organisms evaluated; Nr, number of resistant organisms.
aNo organisms could be isolated for resistance testing.Antibiotic-resistant residential indoor bioaerosols
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organisms recovered inside compared to out-
side the homes, the lack of signiﬁcant differ-
ences in both concentrations of recovered
S. aureus and the percentages of S. aureus
within all heterotrophic organisms recovered
suggests that greater numbers of culturable
antibiotic-resistant S. aureus strains per unit
volume of air are present inside the homes.
Additionally, based on evidence suggesting that
human activities involving the movement of
dry fabrics, such as bed making and curtain
movement, are associated with elevated con-
centrations of airborne bacteria (Das et al.
2002; Roberts et al. 2006), it is reasonable to
assume that elevated concentrations of
S. aureus may exist indoors compared to out-
doors. The health risks associated with occu-
pant exposure to the concentrations we
observed are difﬁcult to calculate because of the
few studies that have reported bacterial aerosol
concentrations in indoor air (IOM 2004) and
the resultant lack of epidemiologic data avail-
able for typical indoor environments. Although
airborne bacteria have been associated with
infectious and allergic respiratory disease
(Heidelberg et al. 1997), research involving
bioaerosol assessment of culturable organisms
in the residential environment has largely
focused on fungi and the allergenic and asth-
matic health effects associated with exposure to
these organisms. The results of the present
study, in combination with the recently
observed trends in the epidemiology of
S. aureus (Chambers 2001) provide sufﬁcient
justiﬁcation for further scientiﬁc evaluation of
both the indoor sources of, and health effects
associated with, indoor residential exposure to
airborne S. aureus. 
The epidemiology of S. aureus has
changed in that there has been a continual
increase in the prevalence of infections caused
by antibiotic-resistant strains of the microbe
(Garcia-Lara et al. 2005; Maranan et al. 1997).
In addition to this increase in prevalence, resis-
tant S. aureus has progressed from being an
organism primarily associated with nosocomial
infection to one that has begun to regularly
infect individuals outside of the hospital setting
(Chambers 2001; Garcia-Lara et al. 2005;
Groom et al. 2001; Herold et al. 1998;
Manranan et al. 1997; Salgado et al. 2003).
The lack of published data documenting pat-
terns in bacterial aerosol concentrations in resi-
dential environments over time precludes our
ability to determine whether there has been an
increase in airborne concentrations of resistant
S. aureus that has occurred in parallel with the
increase in community-acquired infection.
However, our ﬁnding of elevated indoor con-
centrations compared to outdoor reference
samples indicates the need for further evalua-
tion of the implications of this indoor–outdoor
relationship. The extent to which these elevated
concentrations increase the risk of adverse
health outcomes or simply reﬂect the increas-
ing burden of resistant bacteria in our environ-
ment are issues that merit the attention of the
scientiﬁc community. This attention is particu-
larly needed for the most vulnerable in society.
Much of the concern regarding the emer-
gence of resistant S. aureus infections in the
community has resulted from reports of
methicillin-resistant S. aureus (MRSA) iso-
lated from children (Chambers 2001).
S. aureus is a signiﬁcant pathogen in children
and causes illnesses ranging from minor soft
tissue lesions to life-threatening infections
(Marcinak and Frank 2003). Risk factors for
MRSA infection have traditionally been
thought to include intravenous drug use, seri-
ous underlying illness, previous antimicrobial
therapy, prolonged hospitalization, and inva-
sive or surgical procedures (Herold et al.
1998; Maranan et al. 1997). However, since
the 1990s there has been an increase in com-
munity-acquired MRSA infections among
healthy children without known risk factors
[Centers for Disease Control and Prevention
(CDC) 2006; Marcinak and Frank 2003].
This increase has been documented in both
hospital-based studies (Gorak et al. 1999;
Herold et al. 1998; Hussain et al. 2000) and
case reports of outbreaks among newborns
(CDC 2006), as well as infections resulting in
the death of four children in the midwestern
United States (CDC 1999). 
In any investigation, potential confounders
in the role that airborne S. aureus plays in
adverse human health outcomes include its
near ubiquity in the human environment and
its carriage by approximately 30% of healthy
humans (Garcia-Lara et al. 2005). Rates of
infection are higher in carriers than non-
carriers, and nasal carriage of the organism is a
major risk factor for staphylococcal disease
(Peacock et al. 2001). To clearly discern the
role of the airborne bacterium in the causation
of health effects, most epidemiologic investiga-
tions would beneﬁt from separate assessments
of carriers and noncarriers. The near ubiquity
of the organisms in the human environment
presents signiﬁcant challenges in not only the
measurement of airborne concentrations but
also in the determination of potential sources
of any elevated concentrations. These chal-
lenges are present in addition to those already
limiting the assessment of bacterial aerosols in
the indoor environment. These limitations,
while significant, should not prevent future
investigation into this important issue. 
Conclusions 
Culturable S. aureus was recovered inside each
of 24 houses sampled and in 23 of the out-
door reference samples. S. aureus isolates resis-
tant to both penicillin and ampicillin were
recovered inside 22 of 24 study homes,
whereas isolates resistant to cefaclor were
recovered in 14 of 24 homes. Trends in our
data suggest that resistant strains were present
in higher concentrations inside homes com-
pared to outside the homes. The findings of
the present study, in combination with exist-
ing literature documenting the increase in
community-acquired infections caused by resis-
tant strains of S. aureus, indicate the need for
further research into the role that aerosolized
organisms play in the causation of adverse
health of building occupants. 
REFERENCES
Andersen Samplers Inc. 1976. Operating Manual for Andersen
Sampler Inc. Viable Particle Sizing Sampler. Atlanta,
GA:Andersen Samplers Inc.
Barker KF. 1999. Antibiotic resistance: a current perspective.
Br J Clin Pharmacol 48:109–124.
Bauer AW, Kirby WM, Sherris JC, Turck M. 1966. Antibiotic
susceptibility testing by a standardized single disk method.
Am J Clin Pathol 45:493–496.
Beggs CB. 2003. The airborne transmission of infection in hos-
pital buildings: fact or ﬁction? Indoor Built Environ 12:9–18.
CDC (Centers for Disease Control and Prevention). 1999. Four
pediatric deaths from community-acquired methicillin-resis-
tant Staphylococcus aureus—Minnesota and North Dakota,
1997–1999. MMWR Morb Mortal Wkly Rep 48:707–710.
CDC (Centers for Disease Control and Prevention). 2006.
Community-associated methicillin-resistant Staphylococcus
aureus infection among healthy newborns — Chicago and
Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep
55:329–332.
Chambers HF. 2001. The changing epidemiology of Stapyhlo-
coccus aureus? Emerg Infect Dis 7:178–182.
Cohen ML. 1992. Epidemiology of drug resistance: implications
for a postantimicrobial era. Science 257:1050–1055.
Conly J. 2002. Antimicrobial resistance in Canada. Can Med
Assoc J 167:885–891.
Cooper BS, Stone SP, Kibbler CC, Roberts JA, Medley GF,
Duckworth G, et al. 2004. Isolation measures in the hospital
management of methicillin resistant Staphylococcus aureus
(MRSA): a systematic review of the literature. BMJ 329:533.
Cotterill S, Evans R, Fraise AP. 1996. An unusual source for an
outbreak of methicillin-resistant Staphylococcus aureus
on an intensive therapy unit. J Hosp Infect 32:207–216.
Dacarro C, Picco AM, Grisolil P, Rodolﬁ M. 2003. Determination
of aerial microbiological contamination in scholastic
sports environments. J Appl Microbiol 95:904–912. 
Das I, Lambert P, Hill D, Noy M, Bion, Elliot T. 2002. Carbapenem-
resistant Actinobacter and role of curtains in an outbreak in
intensive care units. J Hosp Infect 50:110–114.
Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J,
Jones RN, et al. 2001. Survey of infections due to
Staphylococcus species: frequency of occurrence and
antimicrobial susceptibility of isolates collected in the United
States, Canada, Latin America, Europe, and the Western
Pacific region for the Sentry Antimicrobial Surveillance
Program, 1997–1999. Clin Infect Dis 32:S114–S132.
Garcia-Lara G, Masalha M, Foster SJ. 2005. Staphylococcus
aureus: the search for novel targets. Drug Discov Today
10:643–651.
Gibbs SG, Green CF, Tarwater PM, Mota LC, Mena KD,
Scarpino PV. 2006. Isolation of antibiotic-resistant bacteria
from the air plume downwind of a swine confined or 
concentrated animal feeding operation. Environ Health
Perspect 114:1032–1037.
Gibbs SG, Green CF, Tarwater PM, Scarpino PV. 2004. Airborne
antibiotic resistant and nonresistant bacteria and fungi
recovered from two swine herd confined animal feeding
operations. J Occup Environ Hyg 1(11):699–706. 
Gorak EJ, Yamada SM, Brown JD. 1999. Community acquired
methicillin resistant Staphylococcus aureus in hospitalized
adults and children without known risk factors. Clin Infect
Dis 29:797–800.
Green CF, Pasquale PV, Gibbs SG. 2003. Assessment and model-
ing of indoor fungal and bacterial bioaerosol concentrations.
Aerobiologia 19:159–169.
Groom AV, Wolsey DC, Naimi TS, Smith K, Johnson S, Boxrud D,
et al. 2001. Community acquired methicillin resistantStaphylococcus aureus in a rural American Indian com-
munity. JAMA 286:1201–1205.
Heidelberg JF, Shahamat H, Levin M, Rahman I, Stelma G,
Grim C, et al. 1997. Effect of aerosolization on culturability
and viability of gram-negative bacteria. Appl Environ
Microbiol 63:3585–3588.
Herold BC, Immergluck LC, Maranan MC, Lauderdale DS,
Gaskin RE, Boyle-Vavra S, et al. 1998. Community-acquired
methicillin-resistant Staphylococcus aureus in children
with no identiﬁed predisposing risk. JAMA 279:593–598.
Hussain FM, Boyle-Vavra, S, Bethel, CD, Daum, RS. 2000.
Current trends in community-acquired methicillin-resistant
Staphylococcus aureus at a tertiary care pediatric facility.
Pediatr Infect Dis J 19:1163–1166. 
Hyvarinen A, Vahteristo M, Meklin T, Jantunen M, Nevalainen A,
Moschandreas D. 2001. Temporals and spatial variation of
fungal concentrations in indoor air. Aerosol Sci Technol
35:688–695.
IOM (Institute of Medicine) Committee on Damp Indoor Spaces
and Health. 2004. Damp Indoor Spaces and Health.
Washington, DC:National Academy Press.
Lederberg J, Lederberg EM. 1952. Replica plating and indirect
selection of bacterial mutants. J Bacteriol 63:399–406.
Maranan MC, Moreira B, Boyle-Vavra, Daum RS. 1997.
Antimicrobial resistance in staphylococci: epidemiology,
molecular mechanisms, and clinical relevance. Infect Dis
Clin N Am 11:813–849.
Marcinak JF, Frank AL. 2003. Treatment of community-acquired
methicillin-resistant Staphylococcus aureus in children.
Curr Opin Infect Dis 16:265–269.
Meklin T, Reponen T, Toivola M, Koponen V, Husman T,
Hyvarinen A, et al. 2002. Size distributions of airborne
microbes in moisture-damaged and reference school build-
ings of two construction types. Atmos Environ 36:6031–6039.
NCCLS. 1997. Performance Standards for Antimicrobial Disk
and Dilution Susceptibility Tests. 6th ed. Approved
Standard M2-A6. Wayne, PA:National Committee for
Clinical Laboratory Standards.
NCCLS. 2000. Performance Standards for Antimicrobial
Susceptibility Tests. Approved Standard M7-A5. Wayne,
PA:National Committee for Clinical Laboratory Standards. 
NCCLS. 2001. Performance Standards for Antimicrobial
Susceptibility Testing; Eleventh Informational Supplement.
NCCLS document M100-S11. Wayne, PA:National Committee
for Clinical Laboratory Standards.
Neu HC. 1992. The crisis in antibiotic resistance. Science
257:1064–1073.
Pastuska JS, Paw UKT, Lis DO, Wlazlo A, Ulfig K. 2000.
Bacterial and fungal bioaerosol in indoor environment in
Upper Silesia, Poland. Atmos Environ 34:3833–3842.
Peacock SJ, de Silva I, Lowy FD. 2001. What determines nasal
carriage of Staphylococcus aureus? Trends Microbiol
9:605–610.
Rao GG. 1998. Risk factors for the spread of antibiotic resistant
bacteria. Drugs 55:323–330.
Roberts K, Hathway A, Fletcher LA, Beggs CB, Elliot MW,
Sleigh PA. 2006. Bioaerosol production on a respiratory
ward. Indoor Built Environ 15:135–140.
Roy CJ, Milton DK. 2004. Airborne transmission of communicable
infection – the elusive pathway. New Engl J Med
350:1710–1712.
Salgado CD, Farr BM, Calfee DP. 2003. Community-acquired
methicilliin-resistant Staphylococcus aureus: a meta-
analysis of prevalence and risk factors. Clin Infect Dis
36:131–139.
Smith RD, Coast J. 2002. Antimicrobial resistance: a global
response. Bull WHO 80:126–133.
Sterling DA, Lewis RD. 1998. Pollen and fungal spores indoor
and outdoor of mobile homes. Ann Allergy Asthma
Immunol 80:279–285.
Virk A, Steckelberg JM. 2000. Clinical aspects of antimicrobial
resistance. Mayo Clin Proc 75:200–214.
Wagenvoort JHT, Davies BI, Westerman EJA, Werink TJ,
Toenbreker HMJ. 1993. MRSA from air-exhaust channels.
Lancet 341:840–841.
Gandara et al.
1864 VOLUME 114 | NUMBER 12 | December 2006 • Environmental Health Perspectives